Canada Contrast and Imaging Agents in Interventional X-ray Market Industry Trends and Forecast to 2026

November 2018 | 100 pages | ID: CF689EFBB24EN
Data Bridge Market Research

Abstracts

Canada contrast and imaging agents in Interventional X-ray Market is expected to register a healthy a CAGR of 4.9% in the forecast period of 2019 to 2026. The new market report contains data for the historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

MARKET SEGMENTATION

By Agent Type (Iodinated Contrast Media, Barium-Based Contrast Media, Microbubble Contrast Media, Gold Nanoparticle Contrast Agents, Others), Application (Cardiology, Gastroenterology, Neurology, Oncology, Urology, General Surgery), End User (Imaging Centers, Hospital, Clinics, Diagnostic Center, Ambulatory Surgical Centers, Private Practices)

Major growing sectors under the market segmentation are as follows:

• In agent type, iodinated contrast media are dominating as well as the fastest growing segment in the Canada contrast and imaging agents in interventional X-ray market.
• In application, cardiology is dominating as well as the fastest growing segment in the Canada contrast and imaging agents in interventional X-ray market.
• In end user, imaging centers is dominating as well as the fastest growing segment in the Canada contrast and imaging agents in interventional X-ray market.

The key market players for Canada contrast and imaging agents in interventional X-ray market are listed below:

• General Electric Company
• BRACCO
• Guerbet
• Lantheus Medical Imaging, Inc.
• FUJIFILM VisualSonics Inc.
• Others

Contents

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 YEARS CONSIDERED FOR THE STUDY
2.3 CURRENCY AND PRICING
2.4 RESEARCH METHODOLOGY
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET CHALLENGE MATRIX
2.7 MARKET APPLICATION COVERAGE GRID
2.8 DBMR VENDOR SHARE ANALYSIS
2.9 SECONDARY SOURCES
2.10 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS
  3.1.1 RISING NUMBER OF CHRONIC DISEASES
  3.1.2 RISING AGING POPULATION
  3.1.3 GROWING NUMBER OF DIAGNOSTIC CENTERS
  3.1.4 INCREASE IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES OF CONTRAST AGENTS
3.2 RESTRAINTS
  3.2.1 SIDE EFFECTS ASSOCIATED WITH CONTRAST AGENTS.
3.3 OPPORTUNITIES
  3.3.1 RISING HEALTHCARE EXPENDITURE
  3.3.2 INCREASE IN NUMBER OF PUBLIC AND PRIVATE HOSPITALS
3.4 CHALLENGES
  3.4.1 LACK OF AWARENESS REGARDING THE PROPER DOSAGE OF CONTRAST AGENT

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE

6.1 OVERVIEW
6.2 IODINATED CONTRAST MEDIA
6.3 BARIUM-BASED CONTRAST MEDIA
6.4 MICROBUBBLE CONTRAST MEDIA
6.5 GOLD NANOPARTICLE CONTRAST AGENTS
6.6 OTHERS

7 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 CARDIOLOGY
  7.2.1 PERCUTANEOUS CORONARY INTERVENTION
  7.2.2 STRUCTURAL HEART DISEASE
  7.2.3 CONGENITAL HEART DISEASE
  7.2.4 ELECTROPHYSIOLOGY
7.3 GASTROENTEROLOGY
7.4 NEUROLOGY
7.5 ONCOLOGY
7.6 UROLOGY
7.7 GENERAL SURGERY

8 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER

8.1 OVERVIEW
8.2 IMAGING CENTERS
8.3 HOSPITAL
8.4 CLINICS
8.5 DIAGNOSTIC CENTER
8.6 AMBULATORY SURGICAL CENTERS
8.7 PRIVATE PRACTICES

9 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, COMPANY LANDSCAPE

9.1 COMPANY SHARE ANALYSIS: CANADA

10 COMPANY PROFILES

10.1 GENERAL ELECTRIC COMPANY
  10.1.1 COMPANY SNAPSHOT
  10.1.2 REVENEUE ANALYSIS
  10.1.3 PRODUCT PORTFOLIO
  10.1.4 RECENT DEVELOPMENTS
10.2 BRACCO
  10.2.1 COMPANY SNAPSHOT
  10.2.2 GEOGRAPHICAL PRESENCE
  10.2.3 PRODUCT PORTFOLIO
  10.2.4 RECENT DEVELOPMENTS
10.3 LANTHEUS MEDICAL IMAGING, INC.
  10.3.1 COMPANY SNAPSHOT
  10.3.2 REVENUE ANALYSIS
  10.3.3 PRODUCT PORTFOLIO
  10.3.4 RECENT DEVELOPMENTS
10.4 GUERBET
  10.4.1 COMPANY SNAPSHOT
  10.4.2 REVENEUE ANALYSIS
  10.4.3 PRODUCT PORTFOLIO
  10.4.4 RECENT DEVELOPMENTS
10.5
10.6 FUJIFILM VISUALSONICS INC.
  10.6.1 COMPANY SNAPSHOT
  10.6.2 GEOGRAPHICAL PRESENCE
  10.6.3 PRODUCT PORTFOLIO
  10.6.4 RECENT DEVELOPMENT

11 RELATED REPORTS

12 QUESTIONNAIRE

List Of Tables

LIST OF TABLES

TABLE 1 NUMBER OF DIAGNOSTIC IMAGING EQUIPMENT IN CANADA (2007 & 2017)
TABLE 2 RESEARCH AND DEVELOPMENT EXPENDITURE FOR COMPANIES (USD MILLION) (2016 & 2017)
TABLE 3 AMOUNT OF CONTRAS MEDIA TO BE TAKEN AS PER PATIENT’S WEIGHT
TABLE 4 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION)
TABLE 5 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 6 CANADA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 7 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION)

List Of Figures

LIST OF FIGURES

FIGURE 1 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: SEGMENTATION
FIGURE 2 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: DATA TRIANGULATION
FIGURE 3 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: DROC ANALYSIS
FIGURE 4 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BOTTOM UP APPROACH
FIGURE 5 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: TOP DOWN APPROACH
FIGURE 6 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 8 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET
FIGURE 11 AGEING POPULATION OF CANADA (% OF TOTAL)
FIGURE 12 TOTAL NUMBER OF PHYSICIANS IN CANADA, (2015 & 2018)
FIGURE 13 TOTAL HEALTH SPENDING PER CANADIAN (USD) (2017 & 2018)
FIGURE 14 TOTAL CANADA HEALTH EXPENDITURE, BY SOURCE OF FINANCE, 2016 (USD BILLIONS)
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN CANADA (2015& 2016)
FIGURE 16 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: SEGMENTATION
FIGURE 17 RISING NUMBER OF CHRONIC DISEASES,RISING AGING POPULATION, GROWING NUMBER OF DIAGNOSIC CENTRES AND INCREASE IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES OF CONTRAST AGENTS ARE DRIVING THE MARKET FOR CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET IN THE FORECAST PERIOD 2019 TO 2026
FIGURE 18 IODINATED CONTRAST MEDIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET IN 2019 & 2026
FIGURE 19 KEY PRIMARY INSIGHTS
FIGURE 20 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY AGENT TYPE, 2018
FIGURE 21 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY APPLICATION, 2018
FIGURE 22 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY END USER, 2018
FIGURE 23 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: COMPANY SHARE 2018 (%)